Grow Well Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.35 M
- Revenue Growth 101.77%
- Profit Growth 728.45%
- Ebitda 4.42%
- Net Worth 1.16%
- Total Assets -35.23%
About Grow Well Biotech
Grow Well Biotech Private Limited (GWBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2010 and has a history of 14 years and nine months. Its registered office is in G Konduru, Andhra Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹9.35 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Saritha Chennupati and Tukaram Chennupati serve as directors at the Company.
Company Details
-
Location
G Konduru, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119TG2010PTC068013
-
Company No.
068013
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Grow Well Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saritha Chennupati
|
Director | 28-Dec-2018 | Current |
|
Tukaram Chennupati
|
Director | 20-Apr-2010 | Current |
Financial Performance of Grow Well Biotech.
Grow Well Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 101.77% increase. The company also saw a substantial improvement in profitability, with a 728.45% increase in profit. The company's net worth moved up by a moderate rise of 1.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grow Well Biotech?
In 2023, Grow Well Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹9.35 M
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2010 | Indian Overseas Bank | ₹9.35 M | Satisfied |
How Many Employees Work at Grow Well Biotech?
Unlock and access historical data on people associated with Grow Well Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grow Well Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grow Well Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
